Quick Links
Support Us
The news article "The Fears of the Undocumented: In Chicago, families are preparing for the possibility of being separated by deportations." was talking about Dr. Rusch's clinical work and the Immigrant Family Mental Health Advocacy Program (IFMHA).
Sabetfakhri, N.P., Cook E.H.: Novel approaches for treating psychiatric disorders of childhood onset. In: Charney, D.S., Nestler, E.J., Buxbaum, J.D., Binder, E.B., Gordon, J.A., Picciotto, M.R., editors. Neurobiology of Mental Illness, 6th Edition, 2024, pp. 919-931.
Using depression and anxiety self-report inventory cutoffs to screen for invalid psychiatric symptom overreporting during diagnostic evaluations for Attention-Deficit/Hyperactivity Disorder
Recent publication of Drs. Ajilore, Klumpp and Crane on Frontiers in Adolescent Medicine
Dr. Cooper's publication at the Journal of Neuropsychiatry and Clinical Neurosciences
The Department of Psychiatry is dedicated to outstanding research, education and service focused on major psychiatric disorders and mental well being. We strive to further new, readily useful knowledge in neuroscience, prevention, and social and clinical areas that will benefit people with mental illnesses, their families and communities. We are committed to UIC's urban mission to provide service, education and research that enhances lives. We deliver the highest quality mental health services with sensitivity and respect to the patient and her/his family. We are dedicated to mental health research to ameliorate illness until cure is found and ultimately to prevent illness and disorder. We are dedicated to instilling in our students and trainees cutting-edge knowledge and skills, respect for patients, and the values of a health professional in a just and humane society.
Welcome to the UIC Department of Psychiatry!
No upcoming events.
Dr. Tina Grieco-Calub, PhD, at the University of Illinois – Chicago is conducting a research study that is looking at how visual speech cues affect children’s ability to process language. Your child may be eligible if they:
Researchers at the University of Illinois Chicago are studying whether treatment with injectable extended-release naltrexone (XR-NTX; Vivitrol®) and injectable extended-release Buprenorphine (XR-BUP; Sublocade®) is safe and effective for helping people to cut down or stop using cocaine.
Boarded for the last 6 months.
